Licoricidin (LCD) exhibits antibacterial activity against drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and various oral pathogens; demonstrates anticancer effects by inducing cell cycle arrest, apoptosis, and autophagy in colorectal cancer cells; inhibits tumor angiogenesis, lymphangiogenesis, and pulmonary metastasis; enhances gemcitabine-induced cytotoxicity in osteosarcoma cells via inactivation of Akt and NF-κB pathways; shows anti-photoaging potential by scavenging ROS and suppressing UVA-induced MMP-1 activity, making it a candidate active ingredient in topical anti-aging formulations; possesses anti-inflammatory, immunomodulatory, antioxidant, and neuroprotective pharmacological activities.